A new CT-scan-based risk score facilitates the identification of patients at risk of revision endoscopic sinus surgery due to ...

Please provide your email address to receive an email when new articles are posted on . The need for systemic corticosteroids fell by 88%, and the need for surgery fell by 98%. Nasal polyp and ...

A new CT-scan based risk score facilitates the identification of patients at risk of revision endoscopic sinus surgery due to ...

The global nasal polyps treatment market is expected to reach around $4,243.9 million by 2030, registering a CAGR of 5.6% from 2021 to 2030. WILMINGTON, DE, UNITED STATES, March 13, 2025 ...

Among patients with previous sinus surgery for chronic rhinosinusitis with nasal polyps, the number of past surgeries did not ...

Not only adults, nasal polyps can also occur in children. Polyps are an inflammation of the nasal membranes and sinuses that ...

The prevalence of chronic sinusitis in China is about 8 percent, meaning it affects approximately 107 million people, according to official estimates. Chronic sinusitis with nasal polyps (CRSwNP ...

After Tezspire reduced the need for nasal polyp surgery by 98% in patients with a severe respiratory condition, the biopharma ...

AstraZeneca has failed in its bid to get US approval for its IL-5 inhibitor Fasenra as a treatment for chronic rhinosinusitis in people with nasal polyps, after the FDA rejected its marketing ...

Vasomotor rhinitis is a cause of runny nose and congestion not related to allergies or an infection. Learn about the symptoms ...